"Phenylalanine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE.
| Descriptor ID |
D010649
|
| MeSH Number(s) |
D12.125.072.050.685 D12.125.142.666
|
| Concept/Terms |
Phenylalanine- Phenylalanine
- Phenylalanine, L-Isomer
- L-Isomer Phenylalanine
- Phenylalanine, L Isomer
- L-Phenylalanine
|
Below are MeSH descriptors whose meaning is more general than "Phenylalanine".
Below are MeSH descriptors whose meaning is more specific than "Phenylalanine".
This graph shows the total number of publications written about "Phenylalanine" by people in this website by year, and whether "Phenylalanine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phenylalanine" by people in Profiles.
-
Characterization of Choline Nutriture among Adults and Children with Phenylketonuria. Nutrients. 2022 Sep 29; 14(19).
-
Serotonin Pathway in Cancer. Int J Mol Sci. 2021 Jan 28; 22(3).
-
Arginine-a, ß-dehydrophenylalanine Dipeptide Nanoparticles for pH-Responsive Drug Delivery. Pharm Res. 2018 Jan 16; 35(2):35.
-
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera. Ann Hematol. 2015 Apr; 94(4):717-9.
-
Impact of dietary aromatic amino acids on osteoclastic activity. Calcif Tissue Int. 2014 Aug; 95(2):174-82.
-
Identification of the key residues determining the product specificity of isomerohydrolase. Biochemistry. 2012 May 22; 51(20):4217-25.
-
The Jak2 inhibitor, G6, alleviates Jak2-V617F-mediated myeloproliferative neoplasia by providing significant therapeutic efficacy to the bone marrow. Neoplasia. 2011 Nov; 13(11):1058-68.
-
Importance of Arg-599 of ß-galactosidase (Escherichia coli) as an anchor for the open conformations of Phe-601 and the active-site loop. Biochem Cell Biol. 2010 Dec; 88(6):969-79.
-
In vivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins. Am J Physiol Endocrinol Metab. 2008 Nov; 295(5):E1255-68.
-
Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth. J Biol Chem. 2007 Feb 09; 282(6):3428-32.